Izotropic Corporation News Releases

Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health

Wed, 25 Feb 2026 08:00:00 -0500

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - February 25, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that, further to its February 18th announcement regarding the formation "Izotropic Africa" under a Letter Agreement, the...

Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC

Wed, 18 Feb 2026 08:00:00 -0500

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 18, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into a Letter Agreement (the "Agreement") with a business group ("BG") to establish an entity named...

Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement

Wed, 04 Feb 2026 08:00:00 -0500

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 4, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that further to its January 28, 2026 announcement it has completed a non-brokered private placement financing (the...

Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement

Wed, 28 Jan 2026 08:00:00 -0500

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - January 28, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, provides a corporate update and announces the intention to complete a small non-brokered private placement financing. The Company's...

Izotropic Announces AGM Results

Wed, 31 Dec 2025 16:31:00 -0500

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - December 31, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the results of its Annual General and Special Meeting held on December 29, 2025. Company matters submitted to shareholders...

Izotropic Launches Podcast Episode #2: AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation

Wed, 12 Nov 2025 08:00:00 -0500

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - November 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the release of the second episode in its podcast series: AI and the Future of Breast Imaging: How Izotropic is Leading the...

Izotropic Launches "Breast Imaging News" Page on BreastCT.com

Tue, 28 Oct 2025 08:00:00 -0400

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the launch of the "Breast Imaging News" section on BreastCT.com - a timely and strategic addition to the...

Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook

Thu, 23 Oct 2025 08:00:00 -0400

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the release of a new video interview with the Company's CEO in partnership with Departures Capital. The interview delves...

Izotropic Closes Non-Brokered Private Placement and Engages Awareness Consultants

Fri, 19 Sep 2025 08:00:00 -0400

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that further to its August 26th announcement it has completed a non-brokered private placement financing (the "Offering"),...

Izotropic Gains Visibility as AI Market Broadens Beyond Tech

Wed, 10 Sep 2025 13:24:00 -0400

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 10, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces its sponsored placement in an editorial published on MarketScreener.com. To view the full publication, "From Healthcare to...